Credentialing

The Parkinson Study Group (PSG) is continually interested in expanding our clinical trial sites as opportunities for new Parkinson’s Disease studies become available. Regardless of location (hospital, community-based, academic, or private practice), the PSG seeks trained Parkinson’s disease investigators who are committed to and experienced in clinical trials.

Congratulations to our newest credentialed PSG members!

Credentialed June 2024

  • Jennifer Chen, MD – Site #26 – Rutgers Robert Wood Johnson Medical School
  • Shabbir Hussain Merchant, MD – Site #76 – Beth Israel Deaconess
  • Marco Russo, MD, PhD – Site #26 – Rutgers Robert Wood Johnson Medical School
  • Emily Tamadonfar, MD – Site #33 – University of Southern California
  • Lisa Deuel, MD – Site #37 – University of Vermont

Upcoming Credentialing Deadline​

Quarterly application review:

June 10, 2024

All primary investigators on PSG studies must be credentialed, as well as sub-investigators.

Who Needs to be PSG Credentialed?

All primary investigators on PSG studies must be credentialed, as well as sub-investigators. Our credentialing committee meets quarterly to review all new applications.​​

Upcoming submission deadlines are as follows:

+ March 11, 2024

+ June 10, 2024

+ September 9, 2024

+ December 9, 2024